Abstract
The anti-HIV-1 activities of butanol, hexane, chloroform and water extracts from four widely used folk medicinal plants (Sophora flavescens, Tulipa edulis, Herba ephedra, and Pachyma hoelen Rumph) were evaluated in this study. The hexane extract of Pachyma hoelen Rumph, PH-4, showed effective inhibition against HIV-1. The 50% effective concentration (EC50) of PH-4 was 37.3 μg/ml in the p24 antigen assay and 36.8% in the HIV-1 recombinant RT activity test (at 200 μg/ml). In addition, the PH-4 showed the protective effect on the infected MT-4 cells, with a 58.2% rate of protection. The 50% cytotoxic concentration (CC50) of PH-4 was 100.6 μg/ml. These results suggest that PH-4 from Pachyma hoelen Rumph might be the candidate for the chemotherapy agent against HIV-1 infection with further study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahn, M.J., K.D. Yoon, and C.Y. Kim. 2002. Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts. J. Appl. Phycol. 14, 325–329.
Ahn, M.J., K.D. Yoon, and S.Y. Min. 2004. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga, Ecklonia cava. Biol. Pharm. Bull. 27, 544–547.
Balzarini, J., H. Mitsuya, E. De Clercq, and S. Broder. 1986. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphoadenopathy-associated virus (LAV). Int. J. Cancer 37, 451–457.
Barre-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, C. Gruest, C. Dauguest, and et al. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868–871.
Bedoya, L.M., S. Sanchez-Palomino, M.J. Abad, P. Bermejo, and J. Alcami. 2001. Anti-HIV activity of medicinal plant extracts. J. Ethnopharmcol. 77, 113–116.
Clavel, F. and A.J. Hance. 2004. HIV drug resistance. N. Engl. J. Med. 350, 1023–1035.
De Clercq, E. 2000. Current lead natural products for the chemotherapy of human immuno deficiency virus infection. Med. Res. Rev. 20, 323–349.
Gallo, R.C., P.S. Sarin, E.P. Gelmann, M. Robert-Guroff, E. Richardson, V.S. Kalyanaraman, D. Mann, and et al. 1983. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 220, 865–867.
Goncalves, J., Y. Korin, J. Zack, and D. Gabuzda. 1996. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70, 8701–8709.
Hupfeld, J. and T. Efferth. 2009. Drug resistance of human immunodeficiency virus and overcoming it by natural products. In Vivo 23, 1–6.
Ito, M., A. Sato, K. Hirabayashi, F. Tanabe, S. Shigeta, M. Baba, E. De Clercq, H. Nakashima, and N. Yamamoto. 1988. Mechanism of inhibitory effect of glycyrrhizin on replication human immunodeficiency virus (HIV). Antiviral Res. 10, 289–298.
Klos, M., M. van de Venter, P.J. Milne, H.N. Traore, D. Meyer, and V. Oosthuizen. 2009. In vitro anti-HIV activity of five selected South African medicinal plant extracts. J. Ethnopharmacol. 124, 182–188.
Kong, J.M., N.K. Goh, L.S. Chia, and T.F. Chia. 2003. Recent advances in traditional plant drugs and orchids. Acta Pharmacol. Sin. 24, 7–21.
Lederman, M.M., R.E. Offord, and O. Hartley. 2006. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat. Rev. Immunol. 6, 371–382.
Lipsky, J.J. 1996. Antiretroviral drugs for AIDS. Lancet 348, 800–803.
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.
Patwardhan, B. and M. Gautam. 2005. Botanical immunodrugs: scope and opportunities. Drug Discovery Today 10, 495–502.
Sarin, P.S. 1988. Molecular pharmacologic approaches to the treatment AIDS. Annu. Rev. Pharmacol. Toxicol. 28, 411–428.
Tantillo, C., J. Ding, A. Jacobo-Molina, R.G. Nanni, P.L. Boyer, S.H. Hughes, R. Pauwels, K. Andries, P.A.J. Janssen, and E. Arnold. 1994. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243, 369–387.
Vlietinck, A.J., T. De Bruyne, S. Apers, and L.A. Pieters. 1998. Plantderived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta. Med. 64, 97–109.
Wang, Q., Z.H. Ding, J.K. Liu, and Y.T. Zheng. 2004. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antiviral Res. 64, 189–194.
Wang, R.R., Q. Gu, Y.H. Wang, X.M. Zhang, L.M. Yang, J. Zhou, J.J. Chen, and Y.T. Zheng. 2008. Anti-HIV-1 activities of compounds isolated from the medicinal plant Rhus chinensis. J. Ethnopharmacol. 17, 249–256.
Wang, R.R., Q. Wang, L.M. Gu, J.J. Yang, S. Chen, Y. Li, and Y.T. Zheng. 2006a. Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis. J. Ethnopharmacol. 105, 269–273.
Wang, Q., R.R. Wang, L.M. Yang, W. Li, M. Xu, and Y.T. Zheng. 2006b. Expression, purification of HIV-1 protease and the establishment of a method for protease inhibitor screening. Virologica Sinica 21, 126–130.
Wilkinson, D., L. Gcabashe, and M. Lurie. 1999. Traditional healers as tuberculosis treatment supervisors: precedent and potential. Int. J. Tuberc. Lung Dis. 3, 838–842.
Zheng, Y.T., K.L. Zheng, L. Ben, and S.W. Jin. 2000. Anti-HIV-1 activity of trichosanthin, a novel ribosome-inactivating protein. Acta Pharmacol. Sin. 21, 179–182.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, SA., Hong, SK., Suh, CI. et al. Anti-HIV-1 efficacy of extracts from medicinal plants. J Microbiol. 48, 249–252 (2010). https://doi.org/10.1007/s12275-009-0176-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-009-0176-9